Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Energy & Commerce wants the skinny

This article was originally published in The Tan Sheet

Executive Summary

Subpoena for previously requested information from Skinny Pill for Kids marketer Edita Kaye authorized June 12 by House Energy & Commerce/Subcommittee on Oversight & Investigations. Rep. James Greenwood (R-Penn.) stated Kaye and her counsel "have not provided any responsive documents or narrative responses," instead claiming that because the product was never distributed, she is not obligated to reply. Kaye made similar defense to a NAD inquiry (1"The Tan Sheet" March 31, 2003 In Brief). Committee expanded supplement probe focus beyond ephedra to include pediatric products with March 25 letter to PediaLean manufacturer (2"The Tan Sheet" April 14, 2003, p. 3)...

You may also be interested in...

PediaLean Letter Signals Widening Commerce Cmte. Supplement Probe

The House Energy & Commerce Committee has expanded its investigation of the dietary supplement industry with a letter to the manufacturer of the PediaLean pediatric weight-loss supplement

Skinny Pill discontinued

Fountain of Youth Group has discontinued ad claims for Skinny Pill For Kids and never actually launched the product, according to recent National Advertising Division case report. Council of Better Business Bureaus division disputed claims on Edita Kaye's Web site that supplement is "the first real help in fighting fat" and is "formulated with the finest ingredients to help children reduce their risk of obesity-related diseases." In a letter to NAD, advertiser stated the claims had been "unintentionally published" on the Web site and noted that "while meetings had been held with professionals regarding development of the product, no product had been formulated." Weight-loss supplements marketed to children have received scrutiny from FTC (2"The Tan Sheet" Dec. 16, 2002, p. 5)...

India Approves 16 Applications Under PLI Scheme

India has approved a $46m project by giving the green light to 16 drug production applications under the Production Linked Incentive scheme. The government has ordered the setting up and commercial production of the 16 projects to commence immediately. 





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts